WHITNEY DHYNE: Open Payments
NPI 1043642705 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,677 in 23 payments from 10 companies in 2025. Trend: 2023 $367 · 2024 $636 · 2025 $4,677
Honoraria: $2,775Travel & lodging: $1,171Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| Autolus Inc | 6 | $4,209 |
| Janssen Biotech, Inc. | 6 | $111 |
| Novartis Pharmaceuticals Corporation | 1 | $75 |
| Alexion Pharmaceuticals, Inc. | 2 | $61 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| SANOFI-AVENTIS U.S. LLC | 1 | $45 |
| JAZZ PHARMACEUTICALS INC. | 1 | $40 |
| Janssen Scientific Affairs, LLC | 1 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Legend Biotech USA Inc. | 1 | $24 |
Products named: CARVYKTI, ULTOMIRIS, TALVEY, OJJAARA, TECVAYLI, REZUROCK, DEFITELIO, LIVTENCITY.
Industry payments across TX — which companies pay providers there.
